Improving the lives of our patients.
We work tirelessly to create life changing treatments that help our patients live better and fuller lives.Learn More
Research & Development
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patientsLearn More
We’re pleased to announce the FDA filing acceptance and Priority Review of our supplemental New Drug Application in previously treated IDH1-mutated cholangiocarcinomaLearn More
We are thrilled to announce that Servier Pharmaceuticals has been named one of Boston Business Journal’s 2021 Best Places to Work. Congratulations to all honorees!Learn More
Servier Announces FDA Filing Acceptance and Priority Review for TIBSOVO® (ivosidenib tablets) in IDH1-mutated CholangiocarcinomaLearn More
Adobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business